(JUCY) ETF Series Solutions - Overview
Etf: Treasury Bills, Treasury Notes, GSE Securities
Dividends
| Dividend Yield | 8.26% |
| Yield on Cost 5y | 9.54% |
| Yield CAGR 5y | 130.87% |
| Payout Consistency | 84.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 3.48% |
| Relative Tail Risk | -0.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | 0.12 |
| Character TTM | |
|---|---|
| Beta | 0.062 |
| Beta Downside | 0.080 |
| Drawdowns 3y | |
|---|---|
| Max DD | 1.56% |
| CAGR/Max DD | 2.71 |
Description: JUCY ETF Series Solutions January 01, 2026
The Aptus Enhanced Yield ETF (BATS:JUCY) is an actively managed fund that blends direct holdings of short- and intermediate-term U.S. Treasury bills, Treasury notes, and securities issued by government-sponsored enterprises (GSEs) with exposure obtained through total-return swaps. The swap component is used to augment yield while maintaining a core allocation to high-quality sovereign and quasi-sovereign debt.
Key quantitative drivers (as of the most recent filing) include an expense ratio of roughly 0.55 %, a weighted-average duration near 3.2 years, and a 30-day SEC-yield of about 4.1 %. The fund’s performance is highly sensitive to Federal Reserve policy cycles: rising short-term rates tend to compress the spread between Treasury yields and GSE yields, while a flattening yield curve can reduce the incremental return generated by the swap strategy. Credit spreads on GSE securities (e.g., Fannie Mae, Freddie Mac) serve as a sector-specific risk factor, with widening spreads eroding the ETF’s yield advantage.
If you want a deeper, data-driven view of how JUCY’s risk-return profile compares to peers, the ValueRay platform offers granular analytics that can help you test these assumptions.
What is the price of JUCY shares?
Over the past week, the price has changed by -0.09%, over one month by +0.36%, over three months by +1.42% and over the past year by +4.98%.
Is JUCY a buy, sell or hold?
What are the forecasts/targets for the JUCY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 27.1 | 22.3% |
JUCY Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 224.5m USD (224.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 224.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 224.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.14% (E(224.5m)/V(224.5m) * Re(6.14%) + (debt-free company))
Discount Rate = 6.14% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)